Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amivantamab in Metastatic/Recurrent Penile Squamous Cell Carcinoma (APOLO)
NCT07808359Phase 2Not yet recruiting
- Sponsor
- Latin American Cooperative Oncology Group
- Start
- Nov 2026
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 2 trial of amivantamab in penile squamous cell carcinoma (PSCC), sponsored by Latin American Cooperative Oncology Group. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
amivantamab
03
Conditions
penile squamous cell carcinoma (PSCC)
Beyond the preview
Go deeper on NCT07808359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07808359.